Pfizer Public Service Message a Bit Unappetizing
We appreciate Pfizer's efforts to educate the public on the danger of shady websites peddling countefeit products--but, caution, this one is not for the weak of stomach. Thanks to Drug Channels' Adam...
View ArticleFDA, Hospital at Fault in Levine Case, Not Wyeth
Yesterday's big news was the fact that Wyeth Pharmaceuticals lost its appeal in the precedent setting Wyeth vs. Levine safety labeling case.read more
View ArticleA Contrarian View of FDA: Bloated and Inefficient
John Graham of the conservative California think tank, the Pacific Research Institute, just published a research report, Leviathan's Drug Problem, arguing that FDA is overstaffed, overfunded and...
View ArticlePharmacy Likely to Blame in Deaths of Polo Horses
Some clarity on the cause of the mysterious deaths of 21 polo horses. A Florida pharmacy has concluded that it used incorrect amounts of active ingredients in mixing a vitamin supplement for the...
View ArticleWith Stock Price Fluctuating, Mylan Fires Back at Post-Gazette
In the latest installment of a continuing saga, Mylan Labs is suing the two reporters from the Pittsburgh Post-Gazette who alleged Quality violations at the manufacturer's Morgantown, West Virginia...
View ArticleDrug Recalls Surge! Or Do They?
Conventional wisdom in the industry suggests that drug product recalls are on the rise, and in fact if you look at the chart that leads off this CNN Money report today, you'd say the 2009 escalation is...
View ArticleRethinking Child-Proof Packaging: Can Manufacturers Do More to Stem Pediatric...
A newly published article in the Journal of Pediatrics calls attention to the increasing numbers of children who are poisoned each year by accidentally ingesting medication not intended for them. More...
View ArticleBayer Responds: We've Delivered in Berkeley; Union Demands Unprecedented and...
Bayer and its workers in Berkeley, California, are embroiled in protracted contract negotiations. Last week, we heard from Craig Merrilees, spokesman for the International Longshore & Warehouse...
View ArticleBehold the Master Matrix: How Risk-MaPP Works in the Real World
In September, FDA sent a warning letter to Sichuan Pharmaceutical Co., an API manufacturer in China. The letter cited the manufacturer's failure to adequately guard against potential product...
View ArticleFreakonomics Meets the Drug Supply Chain
Counterfeiting, says Johnson & Johnson’s Ron Guido, is a form of flattery. “If you don’t have counterfeits in your business, chances are you don’t have a good brand,” said Guido, J&J’s VP for...
View Article
